{"gene":"FGF3","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1988,"finding":"FGF3 (int-2) encodes a protein with amino acid homology to the fibroblast growth factor family; four mRNA classes are generated from two alternate transcriptional start sites and two alternate polyadenylation sites, all encoding the same protein product.","method":"cDNA library construction, Northern blot hybridization, primer extension analysis, RNase protection","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal molecular methods establishing transcript structure and protein-coding capacity","pmids":["2841106","3416832"],"is_preprint":false},{"year":1986,"finding":"Mouse FGF3 (int-2) gene comprises at least three exons encoding a 245 amino acid, ~27 kDa protein with homology to the fibroblast growth factor family.","method":"DNA sequencing, cDNA alignment, intron-exon boundary mapping","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — direct sequencing and structural analysis establishing protein-coding domain and gene organization","pmids":["3013624"],"is_preprint":false},{"year":1989,"finding":"INT-2 and kFGF (hst) proteins induce mesoderm formation in isolated Xenopus animal pole explants and stimulate DNA synthesis in mammalian fibroblasts, demonstrating growth factor / mesoderm-inducing activity.","method":"Xenopus animal cap assay, DNA synthesis assay in mammalian fibroblasts","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional assay with defined readouts in two independent systems","pmids":["2483371"],"is_preprint":false},{"year":1990,"finding":"FGF3 (int-2) acts as a potent epithelial growth factor in vivo: MMTV-driven expression in transgenic mice causes mammary gland hyperplasia in females and benign epithelial hyperplasia resembling BPH in the prostate of males.","method":"Transgenic mouse overexpression, histological analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — clean gain-of-function in vivo with defined tissue-specific phenotypic readout","pmids":["1690126"],"is_preprint":false},{"year":1993,"finding":"Mice homozygous for targeted disruption of Fgf3 (int-2) develop defects in the tail (primitive streak/tail bud role) and inner ear (otic vesicle morphogenesis), establishing FGF3 as required for these developmental processes.","method":"Gene targeting / homologous recombination, loss-of-function mouse model, histological phenotyping","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined morphological and functional phenotypes, widely replicated","pmids":["8223243"],"is_preprint":false},{"year":1994,"finding":"A single CUG-initiated form of FGF3 has dual subcellular fates determined by competing signals: secretion is mediated by signal peptide cleavage, while nuclear localization is determined by a bipartite nuclear localization signal that also requires the N-terminal sequences upstream of the signal peptide.","method":"In vitro translation (reticulocyte lysate), transfection in COS-1 cells, deletion/replacement mutagenesis, heterologous fusion protein analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — reconstitution, mutagenesis, and direct localization experiments in one rigorous study","pmids":["8076608"],"is_preprint":false},{"year":1993,"finding":"Xenopus FGF3 (XFGF3) is secreted as glycosylated 31 kDa (p31) and proteolytically processed 27 kDa (p27) forms that bind heparin-Sepharose and the extracellular matrix; conditioned medium containing these proteins induces morphological transformation of NIH3T3 cells and stimulates DNA synthesis in cells expressing FGFR1/2 isoforms.","method":"COS-1 cell transfection, glycosylation analysis, heparin-Sepharose binding, cell-based mitogenicity assay, transformation assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — biochemical characterization combined with functional assays; chimera analysis mapped receptor specificity to C-terminal region","pmids":["8223431"],"is_preprint":false},{"year":1996,"finding":"Zebrafish FGF3 is secreted and associates with the extracellular matrix; its receptor binding preferentially for FGFR2-IIIb rather than IIIc, and C-terminal sequences determine differences in receptor affinity, mitogenic potency, and transforming activity compared to Xenopus FGF3.","method":"COS-1 transfection, heparin-release assay, receptor binding competition, mitogenicity assay, NIH3T3 transformation assay, Xenopus/zebrafish chimeric proteins","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 — in vitro receptor binding and functional assays with chimera dissection","pmids":["8622866"],"is_preprint":false},{"year":2001,"finding":"Zebrafish fgf3 and fgf8 redundantly induce otic placode formation: depletion of either alone causes moderate reduction in otic vesicle size, while combined depletion causes near-complete loss of otic tissue and absence of early otic marker (pax8, pax2.1) expression.","method":"Antisense morpholino knockdown, genetic mutant (ace/fgf8), in situ hybridization for otic markers","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with double morphant/mutant, replicated across multiple zebrafish labs","pmids":["11437442"],"is_preprint":false},{"year":2002,"finding":"In zebrafish, FGF3 and FGF8 act as redundant signals from rhombomere 4 to induce otic placode formation and to establish hindbrain segmental identity (rhombomeres 5 and 6); r4 transplantation and misexpression of either factor can induce r5/r6 markers.","method":"Antisense morpholino knockdown, cell transplantation, gain-of-function misexpression, in situ hybridization","journal":"Development (Cambridge, England) / Current biology : CB","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal genetic and transplantation approaches, replicated independently","pmids":["11959820","12121619","12135921"],"is_preprint":false},{"year":2003,"finding":"In mouse, Fgf3 and Fgf10 together are required for otic vesicle formation: double mutant embryos fail to form otic vesicles, with intermediate phenotypes in embryos carrying three mutant alleles, demonstrating a quantitative requirement for FGF signaling in otic induction.","method":"Double knockout mouse genetics, analysis of otic marker gene expression, cell proliferation assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — clean double KO with defined phenotypic series, independently replicated","pmids":["12810586","14623822"],"is_preprint":false},{"year":2000,"finding":"Ectopic expression of FGF3 in chick embryos induces ectopic otic placodes expressing otic marker genes and forming vesicles with characteristic inner ear gene expression patterns; FGF2 had no such effect, demonstrating specificity of FGF3 in inner ear fate induction.","method":"In ovo gene transfer (chick), ectopic expression, in situ hybridization for otic markers","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function with defined molecular readout and specificity control","pmids":["10769226"],"is_preprint":false},{"year":2007,"finding":"In mouse, Fgf3 expressed in the hindbrain and prospective neurosensory domain is required for dorsal otic patterning and endolymphatic duct formation; Fgf3 acts downstream of Hoxa1/Mafb and upstream of Gbx2 in the WNT-initiated genetic cascade, and prevents ventral expansion of r5-6 Wnt3a expression.","method":"Fgf3 null mouse analysis, in situ hybridization for molecular markers, genetic epistasis placement","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function with molecular pathway placement and epistasis analysis","pmids":["17855431"],"is_preprint":false},{"year":2004,"finding":"Fgf3 signaling from the ventral diencephalon is required non-cell-autonomously to induce lim3, pit1 and other pituitary-specific genes in adenohypophyseal progenitor cells; Fgf3 does not act via Shh signaling in this context.","method":"Zebrafish lia/fgf3 null mutant analysis, in situ hybridization, genetic epistasis with Shh","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — null mutant with defined molecular readout and genetic epistasis excluding Shh pathway","pmids":["15229178"],"is_preprint":false},{"year":2005,"finding":"Endoderm-derived Fgf3, specifically from pharyngeal endodermal pouches, is necessary and sufficient for neurogenesis (phox2a-positive neurons) in zebrafish epibranchial placodes; foxi1 expression in placode precursors is independent of endoderm/Fgf3, indicating Fgf3 acts after initial placode induction.","method":"Morpholino knockdown, tissue transplantation (mosaic analysis), ectopic fgf3 expression, endoderm-deficient embryos","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — cell-autonomous mosaic analysis plus gain- and loss-of-function","pmids":["16077091"],"is_preprint":false},{"year":2001,"finding":"SOX6 binds the Fgf-3 promoter element PS4A and represses Fgf-3 transcription by recruiting the co-repressor CtBP2 via a PLNLSS motif; SOX6 and Fgf-3 show mutually exclusive expression in the otic vesicle.","method":"Yeast one-hybrid screen, yeast two-hybrid, reporter gene assay, co-expression in NIH3T3, mutational analysis, in situ hybridization","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 — direct binding assays, mutagenesis, and functional reporter assays with in vivo expression correlation","pmids":["11504872"],"is_preprint":false},{"year":2004,"finding":"SOX7 and GATA-4 are competitive activators of Fgf-3 transcription through the PS4A promoter element; SOX7 competes with GATA-4 for PS4A occupancy. SOX2 negatively modulates GATA-4-mediated activation. RNA interference against Sox7 abolishes Fgf-3 expression in GATA-4-deficient ES cells.","method":"Reporter gene assay, co-expression experiments, electrophoretic mobility shift (nuclear extracts), RNAi, ES cell differentiation, in situ hybridization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods establishing competitive transcription factor occupancy and functional consequence","pmids":["15082719"],"is_preprint":false},{"year":2016,"finding":"PSM-derived FGF3 acts upstream of BMP signaling in the adjacent neuroepithelium during axis extension: loss of Fgf3 elevates BMP signals causing increased neuroepithelial proliferation, delayed neural tube closure, and premature neural crest specification; reducing BMP signaling (loss of BMP receptor activity) alleviates Fgf3 mutant defects, while increasing BMP (Noggin haploinsufficiency) exacerbates them.","method":"Fgf3 null mouse, genetic epistasis (BMP pathway components), BMP4 treatment of PSM progenitors in vitro, Noggin heterozygous/Fgf3 compound mutants, apoptosis manipulation","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1–2 — rigorous in vivo epistasis with multiple genetic combinations and in vitro phenocopy","pmids":["27144312"],"is_preprint":false},{"year":2008,"finding":"In Ciona intestinalis, FGF3 from the floor plate of the nerve cord directs notochord convergent extension through non-MAPK FGF receptor signaling; dominant-negative FGFR suppresses polarized actin-rich protrusions in notochord cells and disrupts intercalation; inhibiting FGF signaling in Xenopus mesoderm explants perturbs convergent extension and disrupts membrane localization of Dishevelled.","method":"Dominant-negative FGFR expression, morpholino knockdown, live imaging of actin protrusions, Xenopus explant assay, Dishevelled localization","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 — functional assays in a simple chordate model; Xenopus data are pharmacological rather than FGF3-specific","pmids":["19036800"],"is_preprint":false},{"year":2010,"finding":"In chick hindbrain, FGF3 activates the MAPK/ERK pathway and is required for upregulation of the transcription factor Pea3, which in turn is necessary for Krox20 expression in rhombomeres 3 and 5, placing FGF3 upstream of Pea3 in the Krox20 regulatory cascade.","method":"Morpholino knockdown (chick), in situ hybridization, ERK phosphorylation analysis, Pea3 gain/loss-of-function","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — pathway placement by epistasis, single lab","pmids":["20553903"],"is_preprint":false},{"year":2008,"finding":"In chick hindbrain, BMP activity suppresses FGF3 expression, and this suppression requires follistatin-mediated BMP inhibition; FGF3 expression also maintains itself via an autoregulatory loop requiring FGF receptor activity.","method":"Morpholino knockdown (follistatin), BMP overexpression, follistatin protein addition, FGFR inhibitor (SU5402), in situ hybridization","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple perturbation experiments, single lab","pmids":["18823972"],"is_preprint":false},{"year":2009,"finding":"Hindbrain boundary cells are required for downregulation of segmental FGF3 expression: ablation of boundary cells (truncated EphA4 overexpression) or surgical removal of the r3/r4 boundary maintains segmental FGF3 expression at stages when it is normally restricted to boundaries, indicating a boundary-derived soluble repressive signal.","method":"Dominant-negative EphA4 overexpression, surgical boundary ablation, in situ hybridization","journal":"BMC developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — two orthogonal perturbation approaches, single lab","pmids":["19232109"],"is_preprint":false},{"year":1992,"finding":"Wnt-1 and int-2 (FGF3) transgenes cooperate in mammary carcinogenesis: bitransgenic mice develop tumors earlier and with higher frequency than either single transgenic line, and Wnt-1-induced epithelial hyperplasia increases int-2 transgene expression, suggesting that Wnt-1 and FGF3 act in complementary pathways.","method":"Doubly transgenic mice, tumor incidence analysis, RNA expression analysis, in situ hybridization","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic cooperation demonstrated with molecular expression data","pmids":["1530875"],"is_preprint":false},{"year":1992,"finding":"In Xenopus, FGF-3 (int-2) expression is induced by mesoderm induction (bFGF/activin treatment of blastula ectoderm) and by neural induction (heterotypic grafting), and the protein can induce mesoderm from animal caps similarly to other FGFs and posteriorizes embryos.","method":"In situ hybridization, blastula ectoderm treatment, heterotypic grafting, animal cap assay","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 — functional assays in Xenopus with defined inductive readouts","pmids":["1425349"],"is_preprint":false},{"year":1994,"finding":"MCF-10A cells infected with the int-2 oncogene acquire angiogenic activity, inducing blood vessel growth in the chick chorioallantoic membrane and rat mesentery; conditioned medium from int-2-infected cells is sufficient for this activity.","method":"Retroviral infection, chick CAM assay, rat mesentery angiogenesis assay, conditioned medium transfer","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo angiogenesis assays with conditioned medium specificity control","pmids":["7505201"],"is_preprint":false},{"year":1998,"finding":"FGF-3 production in mammary myoepithelial cells stimulates secretion of pro-MMP-9, pro-MMP-2, and plasminogen activators, promoting invasion in Matrigel; this is mechanistically distinct from FGF-4, which has no effect on these proteases.","method":"Retroviral infection of EF43 cells, invasion assay (Matrigel), zymography/proteolytic assay, in vivo tumor transplantation","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — defined molecular mechanism with FGF-4 comparison as specificity control","pmids":["9798677"],"is_preprint":false},{"year":2011,"finding":"Fgf3 and Fgf10 have redundant and dosage-sensitive requirements in murine cardiovascular development: compound mutants show a severity series affecting outflow tract, ventricular septum, AV cushions, ventricular myocardium, epicardium, and fourth pharyngeal arch artery; molecular marker analysis shows abnormalities in each cardiovascular progenitor population without loss of specification.","method":"Compound mouse mutants (allelic series), morphological analysis, molecular marker assessment at multiple time points","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — clean genetic allelic series with defined molecular and morphological readouts, single lab","pmids":["21664901"],"is_preprint":false},{"year":1998,"finding":"Craniofacial dysmorphology (craniosynostosis, Crouzon-like) in mice results from insertional mutation between Fgf3 and Fgf4, which upregulates expression of both Fgf3 and Fgf4 in cranial sutures, confirming FGF signaling pathway involvement in craniofacial development.","method":"Retroviral insertional mutagenesis, transcript analysis, in situ hybridization, histological phenotyping","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2 — molecular demonstration of gain-of-expression causing defined phenotype","pmids":["9626498"],"is_preprint":false},{"year":2002,"finding":"Inducible FGF-3 expression in the mammary gland causes ductal hyperplasia by disrupting the balance between mitogenic and apoptotic signals; RU486 withdrawal reverses the phenotype, and synergism between FGF-3 mitogenic signaling and estrogen is required for pregnancy-dependent tumorigenesis.","method":"Mifepristone-inducible binary transgenic system, histological analysis, apoptosis/proliferation markers","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — inducible and reversible gain-of-function with mechanistic dissection of mitogenic vs. apoptotic balance","pmids":["12169667"],"is_preprint":false},{"year":2001,"finding":"Inducible FGF-3 expression in adult mouse lung causes alveolar macrophage infiltration at low levels and diffuse alveolar type II cell hyperplasia at high levels; both phenotypes are reversible upon ligand withdrawal.","method":"Progesterone antagonist-responsive binary transgenic system, RU486 induction, histological analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — inducible and reversible gain-of-function with dose-dependent phenotypic readouts","pmids":["11331772"],"is_preprint":false},{"year":2008,"finding":"Homozygous FGF3 mutations in humans (p.Leu6Pro within the signal peptide, predicted to impair secretion; and frameshift p.Ile85MetfsX15) cause LAMM syndrome (complete labyrinthine aplasia, microtia, microdontia), confirming FGF3 is required for human inner ear development and that signal peptide integrity is functionally important.","method":"Human genetics (sequencing in consanguineous families), co-segregation analysis, signal peptide prediction","journal":"Clinical genetics","confidence":"Medium","confidence_rationale":"Tier 3 — human LOF mutations with predicted mechanism (signal peptide disruption); no in vitro secretion assay performed in this paper","pmids":["18435799"],"is_preprint":false},{"year":1992,"finding":"Int-2 (FGF3) acts as an autocrine or ultra-short-range paracrine growth factor in mammary epithelium: transplanted mammary tissue expressing int-2 mRNA shows abnormal growth only within the transplant, with no effect on adjacent wild-type host epithelium.","method":"Transgenic tissue transplantation, in situ hybridization for cell-specific mRNA localization, mammary whole-mount analysis","journal":"Journal of the National Cancer Institute","confidence":"Medium","confidence_rationale":"Tier 2 — transplantation experiment with cell-level spatial readout, single lab","pmids":["1317463"],"is_preprint":false}],"current_model":"FGF3 is a heparin-binding secreted growth factor (with an alternative nuclear-localized isoform arising from CUG-initiated translation, whose dual fate is governed by competing signal peptide and bipartite nuclear localization sequences) that signals through FGF receptors (preferentially FGFR2-IIIb) to drive otic placode induction and inner ear morphogenesis (redundantly with FGF10 and FGF8), hindbrain segmental identity via an r4 signaling center (activating MAPK/ERK → Pea3 → Krox20), adenohypophysis specification, epibranchial placode neurogenesis, and cardiovascular progenitor coordination, while its transcription is activated by SOX7/GATA-4 competition and repressed by a SOX6–CtBP2 complex, and its ligand activity is modulated by downstream BMP pathway cross-talk."},"narrative":{"teleology":[{"year":1986,"claim":"Establishing FGF3 as a member of the FGF family resolved the identity of the int-2 proto-oncogene product, showing it encodes a ~27 kDa protein with FGF homology organized across at least three exons, with four mRNA classes from alternate start/polyadenylation sites.","evidence":"cDNA sequencing, Northern blot, primer extension, RNase protection in mouse","pmids":["3013624","2841106","3416832"],"confidence":"High","gaps":["No receptor specificity determined","No functional activity demonstrated at this stage"]},{"year":1989,"claim":"Demonstrating that FGF3 protein has mesoderm-inducing and mitogenic activity established it as a functional growth factor, not merely an oncogene-associated sequence.","evidence":"Xenopus animal cap mesoderm induction assay and mammalian fibroblast DNA synthesis assay","pmids":["2483371"],"confidence":"High","gaps":["Receptor identity unknown","In vivo developmental role not yet tested"]},{"year":1990,"claim":"Transgenic overexpression causing mammary and prostatic epithelial hyperplasia demonstrated that FGF3 acts as a potent epithelial growth factor in vivo, linking it to oncogenic potential in specific tissues.","evidence":"MMTV-driven FGF3 transgenic mice with histological analysis","pmids":["1690126"],"confidence":"High","gaps":["Mechanism of autocrine vs. paracrine action unclear","Receptor specificity in mammary tissue unknown"]},{"year":1992,"claim":"Transplantation studies and Wnt-1/FGF3 bitransgenic analysis established that FGF3 acts as an autocrine/ultra-short-range paracrine factor in mammary epithelium and cooperates with Wnt-1 in mammary tumorigenesis through complementary pathways.","evidence":"Transgenic mammary tissue transplantation; doubly transgenic Wnt-1/int-2 mice with tumor incidence analysis","pmids":["1317463","1530875"],"confidence":"Medium","gaps":["Molecular basis of Wnt-1 and FGF3 pathway complementation not defined","Identity of cooperating downstream effectors unknown"]},{"year":1993,"claim":"Two landmark discoveries — Fgf3 knockout mice showing tail and inner ear defects, and biochemical characterization of secreted glycosylated FGF3 forms binding heparin and activating FGFR1/2 — jointly established FGF3 as a heparin-binding FGFR ligand required for otic vesicle morphogenesis and tail bud development.","evidence":"Targeted gene disruption in mouse; COS-1 cell expression with heparin-Sepharose binding, glycosylation analysis, and FGFR-dependent mitogenicity assays","pmids":["8223243","8223431"],"confidence":"High","gaps":["Specific FGFR isoform preference not yet resolved","Redundancy with other FGFs in ear development not addressed"]},{"year":1994,"claim":"Demonstrating that a single CUG-initiated FGF3 translation product is partitioned between secretory and nuclear fates by competing signal peptide and bipartite NLS resolved the long-standing question of how one mRNA generates two functionally distinct protein pools.","evidence":"In vitro translation, COS-1 transfection, deletion/replacement mutagenesis, heterologous fusion proteins","pmids":["8076608"],"confidence":"High","gaps":["Functional role of nuclear FGF3 undefined","Regulatory mechanism controlling secretory vs. nuclear partitioning in vivo unknown"]},{"year":1996,"claim":"Receptor binding studies with zebrafish/Xenopus FGF3 chimeras established preferential binding to FGFR2-IIIb over IIIc, with C-terminal sequences determining receptor affinity, mitogenic potency, and transforming activity.","evidence":"COS-1 transfection, competition receptor binding assay, chimeric protein analysis","pmids":["8622866"],"confidence":"High","gaps":["Crystal structure of FGF3–FGFR2 complex unavailable","Whether FGFR2-IIIb preference holds in all vertebrate orthologs untested"]},{"year":2001,"claim":"Identification of SOX6–CtBP2 as a transcriptional repressor complex at the Fgf3 promoter, with mutually exclusive SOX6/FGF3 expression in the otic vesicle, established the first direct transcriptional regulatory mechanism for FGF3.","evidence":"Yeast one-hybrid/two-hybrid, reporter gene assay, mutagenesis, in situ hybridization","pmids":["11504872"],"confidence":"High","gaps":["Whether SOX6–CtBP2 repression operates in tissues other than otic vesicle unknown","Chromatin-level mechanism not characterized"]},{"year":2001,"claim":"Morpholino/mutant studies in zebrafish demonstrated that FGF3 and FGF8 redundantly induce otic placode formation, explaining why single-gene knockouts have moderate phenotypes and establishing the principle of FGF ligand redundancy in otic induction.","evidence":"Antisense morpholino knockdown combined with fgf8 (ace) genetic mutant, double depletion, otic marker in situ hybridization","pmids":["11437442"],"confidence":"High","gaps":["Downstream signal transduction pathway in otic precursors not mapped","Whether redundancy extends to other FGF family members not excluded"]},{"year":2002,"claim":"Establishing that FGF3/FGF8 from rhombomere 4 are the instructive signals for both otic placode induction and hindbrain segmental identity (r5/r6) unified two developmental processes under one signaling mechanism.","evidence":"Morpholino knockdown, r4 cell transplantation, gain-of-function misexpression in zebrafish","pmids":["11959820","12121619","12135921"],"confidence":"High","gaps":["How r4 cells restrict FGF3 expression to produce a sharp boundary undefined","Downstream transcription factor targets in r5/r6 specification beyond Krox20 not fully catalogued"]},{"year":2003,"claim":"Mouse Fgf3/Fgf10 double knockouts lacking otic vesicles entirely established that FGF3 and FGF10 (rather than FGF8) are the functionally redundant pair in mammalian otic induction, with a quantitative dosage requirement.","evidence":"Double knockout mouse genetics with allelic series and otic marker analysis","pmids":["12810586","14623822"],"confidence":"High","gaps":["Whether FGF3 and FGF10 activate identical intracellular cascades in otic tissue untested","Cell-autonomous vs. paracrine contributions in mammals not resolved at single-cell level"]},{"year":2004,"claim":"Discovery that SOX7 and GATA-4 competitively activate FGF3 transcription through the same PS4A element, modulated by SOX2, provided the first activating transcriptional mechanism and showed context-dependent promoter occupancy.","evidence":"Reporter assay, EMSA, RNAi in ES cells, co-expression experiments","pmids":["15082719"],"confidence":"High","gaps":["In vivo chromatin occupancy at the endogenous Fgf3 locus not shown","How SOX7/GATA-4 competition is resolved in specific tissues unknown"]},{"year":2004,"claim":"Demonstrating that Fgf3 from the ventral diencephalon is required for adenohypophysis specification (lim3, pit1 induction) independently of Shh expanded FGF3's known roles beyond ear to pituitary development.","evidence":"Zebrafish fgf3 (lia) null mutant analysis with marker gene expression and Shh epistasis","pmids":["15229178"],"confidence":"High","gaps":["FGFR isoform mediating pituitary response unknown","Whether FGF3 acts alone or redundantly with other FGFs in mammalian pituitary not tested"]},{"year":2005,"claim":"Showing that endoderm-derived FGF3 from pharyngeal pouches is necessary and sufficient for epibranchial placode neurogenesis, acting downstream of initial placode induction, defined a new tissue-specific role for FGF3.","evidence":"Morpholino knockdown, mosaic tissue transplantation, ectopic expression, endoderm-deficient embryos in zebrafish","pmids":["16077091"],"confidence":"High","gaps":["Receptor and intracellular pathway in epibranchial placode neurons not identified","Whether other FGFs compensate partially in epibranchial context unknown"]},{"year":2008,"claim":"Identification of human homozygous FGF3 loss-of-function mutations causing LAMM syndrome confirmed that FGF3 is essential for human inner ear, external ear, and dental development and that signal peptide integrity is critical for function.","evidence":"Sequencing of consanguineous families, co-segregation analysis, signal peptide prediction","pmids":["18435799"],"confidence":"Medium","gaps":["No in vitro secretion assay performed for the mutant proteins","Genotype-phenotype correlation across different FGF3 mutations limited"]},{"year":2010,"claim":"Placing FGF3 upstream of MAPK/ERK→Pea3→Krox20 in chick hindbrain completed the signaling cascade linking FGF3 to rhombomere boundary specification.","evidence":"Morpholino knockdown in chick, ERK phosphorylation analysis, Pea3 gain/loss-of-function","pmids":["20553903"],"confidence":"Medium","gaps":["Whether FGF3 activates other MAPK cascade effectors besides Pea3 not tested","Single-lab result awaits independent replication"]},{"year":2011,"claim":"Compound Fgf3/Fgf10 mutant allelic series in mouse revealed dosage-sensitive redundancy in cardiovascular development, extending FGF3 function to outflow tract, ventricular septum, epicardium, and pharyngeal arch artery morphogenesis.","evidence":"Compound mouse mutant allelic series with morphological and molecular marker analysis","pmids":["21664901"],"confidence":"Medium","gaps":["FGFR mediating cardiovascular response not identified","Whether FGF3 cardiovascular role is direct or secondary to pharyngeal endoderm signaling unknown"]},{"year":2016,"claim":"Demonstrating that FGF3 from presomitic mesoderm restrains BMP signaling in adjacent neuroepithelium — with genetic epistasis showing BMP pathway reduction rescues Fgf3 mutant neural tube and crest defects — established FGF3 as a cross-talk node between FGF and BMP pathways during axis extension.","evidence":"Fgf3 null mouse, BMP receptor/Noggin compound mutants, BMP4 treatment of PSM progenitors in vitro","pmids":["27144312"],"confidence":"High","gaps":["Direct molecular mechanism by which FGF3 suppresses BMP transcription/signaling not defined","Whether this FGF–BMP cross-talk operates in other axial tissues unknown"]},{"year":null,"claim":"Key unresolved questions include the biological function of nuclear FGF3, the structural basis of FGFR2-IIIb selectivity, and whether FGF3 plays roles in adult tissue homeostasis beyond developmental contexts.","evidence":"","pmids":[],"confidence":"Low","gaps":["Function of nuclear FGF3 isoform entirely uncharacterized","No crystal structure of FGF3–receptor complex","Adult physiological roles remain unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[2,3,6,7,8,11]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[6,7]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[5,6,7]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[6,7]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,7,8,19]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,8,9,10,11,12,13,14]}],"complexes":[],"partners":["FGFR2","SOX6","CTBP2","SOX7","GATA4","FGF8","FGF10"],"other_free_text":[]},"mechanistic_narrative":"FGF3 is a heparin-binding secreted growth factor of the fibroblast growth factor family that functions as a key paracrine/autocrine signal in embryonic patterning, organogenesis, and epithelial proliferation. A single CUG-initiated translation product is partitioned between secretion (via signal peptide cleavage) and nuclear localization (via a bipartite NLS), and the secreted glycoprotein preferentially activates FGFR2-IIIb to drive MAPK/ERK signaling [PMID:8076608, PMID:8622866]. FGF3 acts redundantly with FGF8 and FGF10 to induce otic placode formation and inner ear morphogenesis, patterns hindbrain segmental identity through an r4 signaling center activating the Pea3→Krox20 cascade, specifies adenohypophyseal progenitors from the ventral diencephalon, and promotes epibranchial placode neurogenesis, while its transcription is positively regulated by SOX7/GATA-4 and repressed by a SOX6–CtBP2 complex [PMID:11437442, PMID:12810586, PMID:15229178, PMID:16077091, PMID:20553903, PMID:11504872, PMID:15082719]. Homozygous loss-of-function FGF3 mutations in humans cause LAMM syndrome (labyrinthine aplasia, microtia, and microdontia), confirming its essential role in inner ear and craniofacial development [PMID:18435799]."},"prefetch_data":{"uniprot":{"accession":"P11487","full_name":"Fibroblast growth factor 3","aliases":["Heparin-binding growth factor 3","HBGF-3","Proto-oncogene Int-2"],"length_aa":239,"mass_kda":26.9,"function":"Plays an important role in the regulation of embryonic development, cell proliferation, and cell differentiation. Required for normal ear development","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P11487/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FGF3","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FGF3","total_profiled":1310},"omim":[{"mim_id":"612202","title":"SRY-BOX 7; SOX7","url":"https://www.omim.org/entry/612202"},{"mim_id":"610706","title":"DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA","url":"https://www.omim.org/entry/610706"},{"mim_id":"610108","title":"ANOCTAMIN 1, CALCIUM-ACTIVATED CHLORIDE CHANNEL; ANO1","url":"https://www.omim.org/entry/610108"},{"mim_id":"608687","title":"SPINOCEREBELLAR ATAXIA 20; SCA20","url":"https://www.omim.org/entry/608687"},{"mim_id":"607224","title":"ORAL CANCER OVEREXPRESSED GENE 1; ORAOV1","url":"https://www.omim.org/entry/607224"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"brain","ntpm":5.2}],"url":"https://www.proteinatlas.org/search/FGF3"},"hgnc":{"alias_symbol":["HBGF-3"],"prev_symbol":["INT2"]},"alphafold":{"accession":"P11487","domains":[{"cath_id":"2.80.10.50","chopping":"43-140_147-195","consensus_level":"high","plddt":94.6827,"start":43,"end":195}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P11487","model_url":"https://alphafold.ebi.ac.uk/files/AF-P11487-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P11487-F1-predicted_aligned_error_v6.png","plddt_mean":78.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FGF3","jax_strain_url":"https://www.jax.org/strain/search?query=FGF3"},"sequence":{"accession":"P11487","fasta_url":"https://rest.uniprot.org/uniprotkb/P11487.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P11487/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P11487"}},"corpus_meta":[{"pmid":"8223243","id":"PMC_8223243","title":"Mice homozygous for a targeted disruption of the proto-oncogene int-2 have developmental defects in the tail and inner ear.","date":"1993","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/8223243","citation_count":402,"is_preprint":false},{"pmid":"3293998","id":"PMC_3293998","title":"Expression of the FGF-related proto-oncogene int-2 during gastrulation and neurulation in the mouse.","date":"1988","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/3293998","citation_count":392,"is_preprint":false},{"pmid":"6327073","id":"PMC_6327073","title":"Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2.","date":"1984","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/6327073","citation_count":349,"is_preprint":false},{"pmid":"3023852","id":"PMC_3023852","title":"Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene.","date":"1986","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/3023852","citation_count":255,"is_preprint":false},{"pmid":"1690126","id":"PMC_1690126","title":"The int-2 gene product acts as an epithelial growth factor in transgenic mice.","date":"1990","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/1690126","citation_count":251,"is_preprint":false},{"pmid":"3013624","id":"PMC_3013624","title":"Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus.","date":"1986","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/3013624","citation_count":238,"is_preprint":false},{"pmid":"12810586","id":"PMC_12810586","title":"Fgf3 and Fgf10 are required for mouse otic placode induction.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12810586","citation_count":238,"is_preprint":false},{"pmid":"2429320","id":"PMC_2429320","title":"Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse development.","date":"1986","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2429320","citation_count":221,"is_preprint":false},{"pmid":"11437442","id":"PMC_11437442","title":"Zebrafish fgf3 and fgf8 encode redundant functions required for otic placode induction.","date":"2001","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11437442","citation_count":211,"is_preprint":false},{"pmid":"11066089","id":"PMC_11066089","title":"Associations of FGF-3 and FGF-10 with signaling networks regulating tooth morphogenesis.","date":"2000","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/11066089","citation_count":210,"is_preprint":false},{"pmid":"11959820","id":"PMC_11959820","title":"Fgf3 and Fgf8 are required together for formation of the otic placode and vesicle.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11959820","citation_count":202,"is_preprint":false},{"pmid":"12385757","id":"PMC_12385757","title":"Fgf8 and Fgf3 are required for zebrafish ear placode induction, maintenance and inner ear patterning.","date":"2002","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/12385757","citation_count":187,"is_preprint":false},{"pmid":"12135921","id":"PMC_12135921","title":"FGF3 and FGF8 mediate a rhombomere 4 signaling activity in the zebrafish hindbrain.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12135921","citation_count":186,"is_preprint":false},{"pmid":"2529025","id":"PMC_2529025","title":"High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas.","date":"1989","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/2529025","citation_count":178,"is_preprint":false},{"pmid":"2548184","id":"PMC_2548184","title":"The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors.","date":"1989","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2548184","citation_count":173,"is_preprint":false},{"pmid":"14623822","id":"PMC_14623822","title":"Requirements for FGF3 and FGF10 during inner ear formation.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/14623822","citation_count":172,"is_preprint":false},{"pmid":"2895446","id":"PMC_2895446","title":"Amplification of human int-2 in breast cancers and squamous carcinomas.","date":"1988","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/2895446","citation_count":166,"is_preprint":false},{"pmid":"7789270","id":"PMC_7789270","title":"Multiple roles for FGF-3 during cranial neural development in the chicken.","date":"1995","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/7789270","citation_count":161,"is_preprint":false},{"pmid":"2193294","id":"PMC_2193294","title":"Amplification of the int-2 gene in human head and neck squamous cell carcinomas.","date":"1990","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/2193294","citation_count":160,"is_preprint":false},{"pmid":"3290903","id":"PMC_3290903","title":"Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer.","date":"1988","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/3290903","citation_count":158,"is_preprint":false},{"pmid":"17906623","id":"PMC_17906623","title":"Duplication of FGF3, FGF4, FGF19 and ORAOV1 causes hair ridge and predisposition to dermoid sinus in Ridgeback dogs.","date":"2007","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17906623","citation_count":156,"is_preprint":false},{"pmid":"2483371","id":"PMC_2483371","title":"Mesoderm-inducing properties of INT-2 and kFGF: two oncogene-encoded growth factors related to FGF.","date":"1989","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/2483371","citation_count":156,"is_preprint":false},{"pmid":"2915903","id":"PMC_2915903","title":"The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci.","date":"1989","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/2915903","citation_count":152,"is_preprint":false},{"pmid":"2841106","id":"PMC_2841106","title":"Multiple RNAs expressed from the int-2 gene in mouse embryonal carcinoma cell lines encode a protein with homology to fibroblast growth factors.","date":"1988","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2841106","citation_count":140,"is_preprint":false},{"pmid":"12121619","id":"PMC_12121619","title":"Establishment of hindbrain segmental identity requires signaling by FGF3 and FGF8.","date":"2002","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/12121619","citation_count":129,"is_preprint":false},{"pmid":"1425349","id":"PMC_1425349","title":"Developmental expression of the Xenopus int-2 (FGF-3) gene: activation by mesodermal and neural induction.","date":"1992","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1425349","citation_count":128,"is_preprint":false},{"pmid":"22890726","id":"PMC_22890726","title":"FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma.","date":"2013","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/22890726","citation_count":126,"is_preprint":false},{"pmid":"1530875","id":"PMC_1530875","title":"Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice.","date":"1992","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/1530875","citation_count":126,"is_preprint":false},{"pmid":"12668634","id":"PMC_12668634","title":"Fgf3 and Fgf8 dependent and independent transcription factors are required for otic placode specification.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12668634","citation_count":122,"is_preprint":false},{"pmid":"1350457","id":"PMC_1350457","title":"Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors.","date":"1992","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/1350457","citation_count":119,"is_preprint":false},{"pmid":"8631508","id":"PMC_8631508","title":"The role of FGF-3 in early inner ear development: an analysis in normal and kreisler mutant mice.","date":"1996","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/8631508","citation_count":114,"is_preprint":false},{"pmid":"8076608","id":"PMC_8076608","title":"Competition between nuclear localization and secretory signals determines the subcellular fate of a single CUG-initiated form of FGF3.","date":"1994","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8076608","citation_count":110,"is_preprint":false},{"pmid":"10769226","id":"PMC_10769226","title":"Induction of inner ear fate by FGF3.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10769226","citation_count":109,"is_preprint":false},{"pmid":"12900450","id":"PMC_12900450","title":"Unique and combinatorial functions of Fgf3 and Fgf8 during zebrafish forebrain development.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12900450","citation_count":106,"is_preprint":false},{"pmid":"15229178","id":"PMC_15229178","title":"Fgf3 signaling from the ventral diencephalon is required for early specification and subsequent survival of the zebrafish adenohypophysis.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15229178","citation_count":106,"is_preprint":false},{"pmid":"2120706","id":"PMC_2120706","title":"Introduction of a lacZ reporter gene into the mouse int-2 locus by homologous recombination.","date":"1990","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2120706","citation_count":94,"is_preprint":false},{"pmid":"2141510","id":"PMC_2141510","title":"Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness.","date":"1990","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/2141510","citation_count":88,"is_preprint":false},{"pmid":"1826231","id":"PMC_1826231","title":"Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas.","date":"1991","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/1826231","citation_count":86,"is_preprint":false},{"pmid":"2565877","id":"PMC_2565877","title":"Linkage analysis of multiple endocrine neoplasia type 1 with INT2 and other markers on chromosome 11.","date":"1989","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/2565877","citation_count":84,"is_preprint":false},{"pmid":"9380415","id":"PMC_9380415","title":"EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer.","date":"1997","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9380415","citation_count":84,"is_preprint":false},{"pmid":"17601531","id":"PMC_17601531","title":"Differential requirements for FGF3, FGF8 and FGF10 during inner ear development.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17601531","citation_count":82,"is_preprint":false},{"pmid":"2470007","id":"PMC_2470007","title":"Sequence organization of the human int-2 gene and its expression in teratocarcinoma cells.","date":"1989","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/2470007","citation_count":81,"is_preprint":false},{"pmid":"3133332","id":"PMC_3133332","title":"Coamplification of the hst-1 and int-2 genes in human cancers.","date":"1988","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/3133332","citation_count":79,"is_preprint":false},{"pmid":"17855431","id":"PMC_17855431","title":"Fgf3 is required for dorsal patterning and morphogenesis of the inner ear epithelium.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17855431","citation_count":77,"is_preprint":false},{"pmid":"3416832","id":"PMC_3416832","title":"Four classes of mRNA are expressed from the mouse int-2 gene, a member of the FGF gene family.","date":"1988","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/3416832","citation_count":77,"is_preprint":false},{"pmid":"9879707","id":"PMC_9879707","title":"Expression and functions of FGF-3 in Xenopus development.","date":"1998","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9879707","citation_count":76,"is_preprint":false},{"pmid":"8800419","id":"PMC_8800419","title":"Expression of Fgf-3 in relation to hindbrain segmentation, otic pit position and pharyngeal arch morphology in normal and retinoic acid-exposed mouse embryos.","date":"1996","source":"Anatomy and embryology","url":"https://pubmed.ncbi.nlm.nih.gov/8800419","citation_count":74,"is_preprint":false},{"pmid":"3472240","id":"PMC_3472240","title":"The progesterone receptor gene maps to human chromosome band 11q13, the site of the mammary oncogene int-2.","date":"1987","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/3472240","citation_count":71,"is_preprint":false},{"pmid":"7539284","id":"PMC_7539284","title":"Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas.","date":"1995","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/7539284","citation_count":69,"is_preprint":false},{"pmid":"2611995","id":"PMC_2611995","title":"Amplification of the proto-oncogenes int-2, c-erb B-2 and c-myc in human breast cancer.","date":"1989","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2611995","citation_count":68,"is_preprint":false},{"pmid":"8831628","id":"PMC_8831628","title":"Gene defect in hypodontia: exclusion of EGF, EGFR, and FGF-3 as candidate genes.","date":"1996","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/8831628","citation_count":65,"is_preprint":false},{"pmid":"11504872","id":"PMC_11504872","title":"SOX6 binds CtBP2 to repress transcription from the Fgf-3 promoter.","date":"2001","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11504872","citation_count":63,"is_preprint":false},{"pmid":"3060118","id":"PMC_3060118","title":"Differential expression of two homologous and clustered oncogenes, Hst1 and Int-2, during differentiation of F9 cells.","date":"1988","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/3060118","citation_count":61,"is_preprint":false},{"pmid":"6321961","id":"PMC_6321961","title":"Mouse mammary tumor virus integration regions int-1 and int-2 map on different mouse chromosomes.","date":"1984","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/6321961","citation_count":61,"is_preprint":false},{"pmid":"16077091","id":"PMC_16077091","title":"Endoderm-derived Fgf3 is necessary and sufficient for inducing neurogenesis in the epibranchial placodes in zebrafish.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16077091","citation_count":58,"is_preprint":false},{"pmid":"10685630","id":"PMC_10685630","title":"Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma.","date":"2000","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/10685630","citation_count":58,"is_preprint":false},{"pmid":"1975511","id":"PMC_1975511","title":"Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas.","date":"1990","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/1975511","citation_count":55,"is_preprint":false},{"pmid":"12399318","id":"PMC_12399318","title":"An expanded domain of fgf3 expression in the hindbrain of zebrafish valentino mutants results in mis-patterning of the otic vesicle.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12399318","citation_count":53,"is_preprint":false},{"pmid":"2740210","id":"PMC_2740210","title":"The mouse homologue of hst/k-FGF: sequence, genome organization and location relative to int-2.","date":"1989","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/2740210","citation_count":53,"is_preprint":false},{"pmid":"8449602","id":"PMC_8449602","title":"int-2 amplification in breast cancer: association with decreased survival and relationship to amplification of c-erbB-2 and c-myc.","date":"1993","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/8449602","citation_count":52,"is_preprint":false},{"pmid":"3029401","id":"PMC_3029401","title":"Activation of int-1 and int-2 mammary oncogenes in hormone-dependent and -independent mammary tumors of GR mice.","date":"1987","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/3029401","citation_count":52,"is_preprint":false},{"pmid":"19036800","id":"PMC_19036800","title":"FGF3 in the floor plate directs notochord convergent extension in the Ciona tadpole.","date":"2008","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19036800","citation_count":51,"is_preprint":false},{"pmid":"15082719","id":"PMC_15082719","title":"SOX7 and GATA-4 are competitive activators of Fgf-3 transcription.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15082719","citation_count":50,"is_preprint":false},{"pmid":"9626498","id":"PMC_9626498","title":"Crouzon-like craniofacial dysmorphology in the mouse is caused by an insertional mutation at the Fgf3/Fgf4 locus.","date":"1998","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/9626498","citation_count":49,"is_preprint":false},{"pmid":"7999362","id":"PMC_7999362","title":"Targeted disruption of int-2 (fgf-3) causes developmental defects in the tail and inner ear.","date":"1994","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/7999362","citation_count":47,"is_preprint":false},{"pmid":"20018768","id":"PMC_20018768","title":"Modulation of Fgf3 dosage in mouse and men mirrors evolution of mammalian dentition.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20018768","citation_count":46,"is_preprint":false},{"pmid":"17656375","id":"PMC_17656375","title":"SNP genome scanning localizes oto-dental syndrome to chromosome 11q13 and microdeletions at this locus implicate FGF3 in dental and inner-ear disease and FADD in ocular coloboma.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17656375","citation_count":46,"is_preprint":false},{"pmid":"7685625","id":"PMC_7685625","title":"Amplified region of chromosome band 11q13 in breast and squamous cell carcinomas encompasses three CpG islands telomeric of FGF3, including the expressed gene EMS1.","date":"1993","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/7685625","citation_count":44,"is_preprint":false},{"pmid":"8654946","id":"PMC_8654946","title":"The zebrafish Fgf-3 gene: cDNA sequence, transcript structure and genomic organization.","date":"1996","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8654946","citation_count":43,"is_preprint":false},{"pmid":"21664901","id":"PMC_21664901","title":"Redundant and dosage sensitive requirements for Fgf3 and Fgf10 in cardiovascular development.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21664901","citation_count":41,"is_preprint":false},{"pmid":"2974287","id":"PMC_2974287","title":"Two homologous oncogenes, HST1 and INT2, are closely located in human genome.","date":"1988","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/2974287","citation_count":41,"is_preprint":false},{"pmid":"18435799","id":"PMC_18435799","title":"Homozygous FGF3 mutations result in congenital deafness with inner ear agenesis, microtia, and microdontia.","date":"2008","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18435799","citation_count":41,"is_preprint":false},{"pmid":"1826346","id":"PMC_1826346","title":"GST pi gene is frequently coamplified with INT2 and HSTF1 proto-oncogenes in human breast cancers.","date":"1991","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/1826346","citation_count":40,"is_preprint":false},{"pmid":"27144312","id":"PMC_27144312","title":"An FGF3-BMP Signaling Axis Regulates Caudal Neural Tube Closure, Neural Crest Specification and Anterior-Posterior Axis Extension.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27144312","citation_count":40,"is_preprint":false},{"pmid":"8424907","id":"PMC_8424907","title":"Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor.","date":"1993","source":"Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/8424907","citation_count":39,"is_preprint":false},{"pmid":"7768000","id":"PMC_7768000","title":"Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template.","date":"1995","source":"Clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7768000","citation_count":38,"is_preprint":false},{"pmid":"8522248","id":"PMC_8522248","title":"DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancer.","date":"1995","source":"Gynecologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/8522248","citation_count":38,"is_preprint":false},{"pmid":"8105839","id":"PMC_8105839","title":"HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples.","date":"1993","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/8105839","citation_count":36,"is_preprint":false},{"pmid":"1317463","id":"PMC_1317463","title":"Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants.","date":"1992","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/1317463","citation_count":35,"is_preprint":false},{"pmid":"1920494","id":"PMC_1920494","title":"Her-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones.","date":"1991","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/1920494","citation_count":32,"is_preprint":false},{"pmid":"11331772","id":"PMC_11331772","title":"Phenotypic consequences of lung-specific inducible expression of FGF-3.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11331772","citation_count":32,"is_preprint":false},{"pmid":"3060803","id":"PMC_3060803","title":"The FGF-related oncogene, K-FGF, maps to human chromosome region 11q13, possibly near int-2.","date":"1988","source":"Oncogene research","url":"https://pubmed.ncbi.nlm.nih.gov/3060803","citation_count":32,"is_preprint":false},{"pmid":"8223431","id":"PMC_8223431","title":"FGF3 from Xenopus laevis.","date":"1993","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8223431","citation_count":32,"is_preprint":false},{"pmid":"8494710","id":"PMC_8494710","title":"First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer.","date":"1993","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/8494710","citation_count":31,"is_preprint":false},{"pmid":"18823972","id":"PMC_18823972","title":"Inhibition of BMPs by follistatin is required for FGF3 expression and segmental patterning of the hindbrain.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18823972","citation_count":30,"is_preprint":false},{"pmid":"2157060","id":"PMC_2157060","title":"Insertion mutation of the int-1 and int-2 loci by mouse mammary tumor virus in premalignant and malignant neoplasms from the GR mouse strain.","date":"1990","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/2157060","citation_count":30,"is_preprint":false},{"pmid":"8784015","id":"PMC_8784015","title":"Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas.","date":"1996","source":"The Annals of thoracic surgery","url":"https://pubmed.ncbi.nlm.nih.gov/8784015","citation_count":30,"is_preprint":false},{"pmid":"19232109","id":"PMC_19232109","title":"Boundary cells regulate a switch in the expression of FGF3 in hindbrain rhombomeres.","date":"2009","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19232109","citation_count":29,"is_preprint":false},{"pmid":"9798677","id":"PMC_9798677","title":"FGF-3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9798677","citation_count":28,"is_preprint":false},{"pmid":"2153243","id":"PMC_2153243","title":"Proviral insertions within the int-2 gene can generate multiple anomalous transcripts but leave the protein-coding domain intact.","date":"1990","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/2153243","citation_count":28,"is_preprint":false},{"pmid":"18701883","id":"PMC_18701883","title":"Syndromic congenital sensorineural deafness, microtia and microdontia resulting from a novel homoallelic mutation in fibroblast growth factor 3 (FGF3).","date":"2008","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/18701883","citation_count":28,"is_preprint":false},{"pmid":"2491259","id":"PMC_2491259","title":"The structure and function of the int-2 oncogene.","date":"1989","source":"Progress in growth factor research","url":"https://pubmed.ncbi.nlm.nih.gov/2491259","citation_count":27,"is_preprint":false},{"pmid":"29073177","id":"PMC_29073177","title":"Hypomethylated Fgf3 is a potential biomarker for early detection of oral cancer in mice treated with the tobacco carcinogen dibenzo[def,p]chrysene.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29073177","citation_count":26,"is_preprint":false},{"pmid":"10786811","id":"PMC_10786811","title":"FGF4 and INT2 oncogenes are amplified and expressed in Kaposi's sarcoma.","date":"2000","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/10786811","citation_count":25,"is_preprint":false},{"pmid":"20553903","id":"PMC_20553903","title":"Analysis of expression and function of FGF-MAPK signaling components in the hindbrain reveals a central role for FGF3 in the regulation of Krox20, mediated by Pea3.","date":"2010","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20553903","citation_count":25,"is_preprint":false},{"pmid":"7505201","id":"PMC_7505201","title":"MCF-10A cells infected with the int-2 oncogene induce angiogenesis in the chick chorioallantoic membrane and in the rat mesentery.","date":"1994","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/7505201","citation_count":25,"is_preprint":false},{"pmid":"8622866","id":"PMC_8622866","title":"Secretion and mitogenic activity of zebrafish FGF3 reveal intermediate properties relative to mouse and Xenopus homologues.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8622866","citation_count":24,"is_preprint":false},{"pmid":"8100482","id":"PMC_8100482","title":"Growth-stimulating activity of interleukin 6 on human mammary epithelial cells transfected with the int-2 gene.","date":"1993","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/8100482","citation_count":24,"is_preprint":false},{"pmid":"1712864","id":"PMC_1712864","title":"Host genetic background effect on the frequency of mouse mammary tumor virus-induced rearrangements of the int-1 and int-2 loci in mouse mammary tumors.","date":"1991","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/1712864","citation_count":24,"is_preprint":false},{"pmid":"12169667","id":"PMC_12169667","title":"Inducible expression of FGF-3 in mouse mammary gland.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12169667","citation_count":22,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45056,"output_tokens":6937,"usd":0.119611},"stage2":{"model":"claude-opus-4-6","input_tokens":10665,"output_tokens":4129,"usd":0.234825},"total_usd":0.354436,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1988,\n      \"finding\": \"FGF3 (int-2) encodes a protein with amino acid homology to the fibroblast growth factor family; four mRNA classes are generated from two alternate transcriptional start sites and two alternate polyadenylation sites, all encoding the same protein product.\",\n      \"method\": \"cDNA library construction, Northern blot hybridization, primer extension analysis, RNase protection\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal molecular methods establishing transcript structure and protein-coding capacity\",\n      \"pmids\": [\"2841106\", \"3416832\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"Mouse FGF3 (int-2) gene comprises at least three exons encoding a 245 amino acid, ~27 kDa protein with homology to the fibroblast growth factor family.\",\n      \"method\": \"DNA sequencing, cDNA alignment, intron-exon boundary mapping\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct sequencing and structural analysis establishing protein-coding domain and gene organization\",\n      \"pmids\": [\"3013624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"INT-2 and kFGF (hst) proteins induce mesoderm formation in isolated Xenopus animal pole explants and stimulate DNA synthesis in mammalian fibroblasts, demonstrating growth factor / mesoderm-inducing activity.\",\n      \"method\": \"Xenopus animal cap assay, DNA synthesis assay in mammalian fibroblasts\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional assay with defined readouts in two independent systems\",\n      \"pmids\": [\"2483371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"FGF3 (int-2) acts as a potent epithelial growth factor in vivo: MMTV-driven expression in transgenic mice causes mammary gland hyperplasia in females and benign epithelial hyperplasia resembling BPH in the prostate of males.\",\n      \"method\": \"Transgenic mouse overexpression, histological analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean gain-of-function in vivo with defined tissue-specific phenotypic readout\",\n      \"pmids\": [\"1690126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Mice homozygous for targeted disruption of Fgf3 (int-2) develop defects in the tail (primitive streak/tail bud role) and inner ear (otic vesicle morphogenesis), establishing FGF3 as required for these developmental processes.\",\n      \"method\": \"Gene targeting / homologous recombination, loss-of-function mouse model, histological phenotyping\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined morphological and functional phenotypes, widely replicated\",\n      \"pmids\": [\"8223243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"A single CUG-initiated form of FGF3 has dual subcellular fates determined by competing signals: secretion is mediated by signal peptide cleavage, while nuclear localization is determined by a bipartite nuclear localization signal that also requires the N-terminal sequences upstream of the signal peptide.\",\n      \"method\": \"In vitro translation (reticulocyte lysate), transfection in COS-1 cells, deletion/replacement mutagenesis, heterologous fusion protein analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution, mutagenesis, and direct localization experiments in one rigorous study\",\n      \"pmids\": [\"8076608\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Xenopus FGF3 (XFGF3) is secreted as glycosylated 31 kDa (p31) and proteolytically processed 27 kDa (p27) forms that bind heparin-Sepharose and the extracellular matrix; conditioned medium containing these proteins induces morphological transformation of NIH3T3 cells and stimulates DNA synthesis in cells expressing FGFR1/2 isoforms.\",\n      \"method\": \"COS-1 cell transfection, glycosylation analysis, heparin-Sepharose binding, cell-based mitogenicity assay, transformation assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — biochemical characterization combined with functional assays; chimera analysis mapped receptor specificity to C-terminal region\",\n      \"pmids\": [\"8223431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Zebrafish FGF3 is secreted and associates with the extracellular matrix; its receptor binding preferentially for FGFR2-IIIb rather than IIIc, and C-terminal sequences determine differences in receptor affinity, mitogenic potency, and transforming activity compared to Xenopus FGF3.\",\n      \"method\": \"COS-1 transfection, heparin-release assay, receptor binding competition, mitogenicity assay, NIH3T3 transformation assay, Xenopus/zebrafish chimeric proteins\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro receptor binding and functional assays with chimera dissection\",\n      \"pmids\": [\"8622866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Zebrafish fgf3 and fgf8 redundantly induce otic placode formation: depletion of either alone causes moderate reduction in otic vesicle size, while combined depletion causes near-complete loss of otic tissue and absence of early otic marker (pax8, pax2.1) expression.\",\n      \"method\": \"Antisense morpholino knockdown, genetic mutant (ace/fgf8), in situ hybridization for otic markers\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with double morphant/mutant, replicated across multiple zebrafish labs\",\n      \"pmids\": [\"11437442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"In zebrafish, FGF3 and FGF8 act as redundant signals from rhombomere 4 to induce otic placode formation and to establish hindbrain segmental identity (rhombomeres 5 and 6); r4 transplantation and misexpression of either factor can induce r5/r6 markers.\",\n      \"method\": \"Antisense morpholino knockdown, cell transplantation, gain-of-function misexpression, in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England) / Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal genetic and transplantation approaches, replicated independently\",\n      \"pmids\": [\"11959820\", \"12121619\", \"12135921\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In mouse, Fgf3 and Fgf10 together are required for otic vesicle formation: double mutant embryos fail to form otic vesicles, with intermediate phenotypes in embryos carrying three mutant alleles, demonstrating a quantitative requirement for FGF signaling in otic induction.\",\n      \"method\": \"Double knockout mouse genetics, analysis of otic marker gene expression, cell proliferation assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double KO with defined phenotypic series, independently replicated\",\n      \"pmids\": [\"12810586\", \"14623822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Ectopic expression of FGF3 in chick embryos induces ectopic otic placodes expressing otic marker genes and forming vesicles with characteristic inner ear gene expression patterns; FGF2 had no such effect, demonstrating specificity of FGF3 in inner ear fate induction.\",\n      \"method\": \"In ovo gene transfer (chick), ectopic expression, in situ hybridization for otic markers\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function with defined molecular readout and specificity control\",\n      \"pmids\": [\"10769226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In mouse, Fgf3 expressed in the hindbrain and prospective neurosensory domain is required for dorsal otic patterning and endolymphatic duct formation; Fgf3 acts downstream of Hoxa1/Mafb and upstream of Gbx2 in the WNT-initiated genetic cascade, and prevents ventral expansion of r5-6 Wnt3a expression.\",\n      \"method\": \"Fgf3 null mouse analysis, in situ hybridization for molecular markers, genetic epistasis placement\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with molecular pathway placement and epistasis analysis\",\n      \"pmids\": [\"17855431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Fgf3 signaling from the ventral diencephalon is required non-cell-autonomously to induce lim3, pit1 and other pituitary-specific genes in adenohypophyseal progenitor cells; Fgf3 does not act via Shh signaling in this context.\",\n      \"method\": \"Zebrafish lia/fgf3 null mutant analysis, in situ hybridization, genetic epistasis with Shh\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — null mutant with defined molecular readout and genetic epistasis excluding Shh pathway\",\n      \"pmids\": [\"15229178\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Endoderm-derived Fgf3, specifically from pharyngeal endodermal pouches, is necessary and sufficient for neurogenesis (phox2a-positive neurons) in zebrafish epibranchial placodes; foxi1 expression in placode precursors is independent of endoderm/Fgf3, indicating Fgf3 acts after initial placode induction.\",\n      \"method\": \"Morpholino knockdown, tissue transplantation (mosaic analysis), ectopic fgf3 expression, endoderm-deficient embryos\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-autonomous mosaic analysis plus gain- and loss-of-function\",\n      \"pmids\": [\"16077091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"SOX6 binds the Fgf-3 promoter element PS4A and represses Fgf-3 transcription by recruiting the co-repressor CtBP2 via a PLNLSS motif; SOX6 and Fgf-3 show mutually exclusive expression in the otic vesicle.\",\n      \"method\": \"Yeast one-hybrid screen, yeast two-hybrid, reporter gene assay, co-expression in NIH3T3, mutational analysis, in situ hybridization\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct binding assays, mutagenesis, and functional reporter assays with in vivo expression correlation\",\n      \"pmids\": [\"11504872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SOX7 and GATA-4 are competitive activators of Fgf-3 transcription through the PS4A promoter element; SOX7 competes with GATA-4 for PS4A occupancy. SOX2 negatively modulates GATA-4-mediated activation. RNA interference against Sox7 abolishes Fgf-3 expression in GATA-4-deficient ES cells.\",\n      \"method\": \"Reporter gene assay, co-expression experiments, electrophoretic mobility shift (nuclear extracts), RNAi, ES cell differentiation, in situ hybridization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods establishing competitive transcription factor occupancy and functional consequence\",\n      \"pmids\": [\"15082719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PSM-derived FGF3 acts upstream of BMP signaling in the adjacent neuroepithelium during axis extension: loss of Fgf3 elevates BMP signals causing increased neuroepithelial proliferation, delayed neural tube closure, and premature neural crest specification; reducing BMP signaling (loss of BMP receptor activity) alleviates Fgf3 mutant defects, while increasing BMP (Noggin haploinsufficiency) exacerbates them.\",\n      \"method\": \"Fgf3 null mouse, genetic epistasis (BMP pathway components), BMP4 treatment of PSM progenitors in vitro, Noggin heterozygous/Fgf3 compound mutants, apoptosis manipulation\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — rigorous in vivo epistasis with multiple genetic combinations and in vitro phenocopy\",\n      \"pmids\": [\"27144312\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In Ciona intestinalis, FGF3 from the floor plate of the nerve cord directs notochord convergent extension through non-MAPK FGF receptor signaling; dominant-negative FGFR suppresses polarized actin-rich protrusions in notochord cells and disrupts intercalation; inhibiting FGF signaling in Xenopus mesoderm explants perturbs convergent extension and disrupts membrane localization of Dishevelled.\",\n      \"method\": \"Dominant-negative FGFR expression, morpholino knockdown, live imaging of actin protrusions, Xenopus explant assay, Dishevelled localization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assays in a simple chordate model; Xenopus data are pharmacological rather than FGF3-specific\",\n      \"pmids\": [\"19036800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In chick hindbrain, FGF3 activates the MAPK/ERK pathway and is required for upregulation of the transcription factor Pea3, which in turn is necessary for Krox20 expression in rhombomeres 3 and 5, placing FGF3 upstream of Pea3 in the Krox20 regulatory cascade.\",\n      \"method\": \"Morpholino knockdown (chick), in situ hybridization, ERK phosphorylation analysis, Pea3 gain/loss-of-function\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway placement by epistasis, single lab\",\n      \"pmids\": [\"20553903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In chick hindbrain, BMP activity suppresses FGF3 expression, and this suppression requires follistatin-mediated BMP inhibition; FGF3 expression also maintains itself via an autoregulatory loop requiring FGF receptor activity.\",\n      \"method\": \"Morpholino knockdown (follistatin), BMP overexpression, follistatin protein addition, FGFR inhibitor (SU5402), in situ hybridization\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple perturbation experiments, single lab\",\n      \"pmids\": [\"18823972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Hindbrain boundary cells are required for downregulation of segmental FGF3 expression: ablation of boundary cells (truncated EphA4 overexpression) or surgical removal of the r3/r4 boundary maintains segmental FGF3 expression at stages when it is normally restricted to boundaries, indicating a boundary-derived soluble repressive signal.\",\n      \"method\": \"Dominant-negative EphA4 overexpression, surgical boundary ablation, in situ hybridization\",\n      \"journal\": \"BMC developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two orthogonal perturbation approaches, single lab\",\n      \"pmids\": [\"19232109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Wnt-1 and int-2 (FGF3) transgenes cooperate in mammary carcinogenesis: bitransgenic mice develop tumors earlier and with higher frequency than either single transgenic line, and Wnt-1-induced epithelial hyperplasia increases int-2 transgene expression, suggesting that Wnt-1 and FGF3 act in complementary pathways.\",\n      \"method\": \"Doubly transgenic mice, tumor incidence analysis, RNA expression analysis, in situ hybridization\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic cooperation demonstrated with molecular expression data\",\n      \"pmids\": [\"1530875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"In Xenopus, FGF-3 (int-2) expression is induced by mesoderm induction (bFGF/activin treatment of blastula ectoderm) and by neural induction (heterotypic grafting), and the protein can induce mesoderm from animal caps similarly to other FGFs and posteriorizes embryos.\",\n      \"method\": \"In situ hybridization, blastula ectoderm treatment, heterotypic grafting, animal cap assay\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assays in Xenopus with defined inductive readouts\",\n      \"pmids\": [\"1425349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"MCF-10A cells infected with the int-2 oncogene acquire angiogenic activity, inducing blood vessel growth in the chick chorioallantoic membrane and rat mesentery; conditioned medium from int-2-infected cells is sufficient for this activity.\",\n      \"method\": \"Retroviral infection, chick CAM assay, rat mesentery angiogenesis assay, conditioned medium transfer\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo angiogenesis assays with conditioned medium specificity control\",\n      \"pmids\": [\"7505201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"FGF-3 production in mammary myoepithelial cells stimulates secretion of pro-MMP-9, pro-MMP-2, and plasminogen activators, promoting invasion in Matrigel; this is mechanistically distinct from FGF-4, which has no effect on these proteases.\",\n      \"method\": \"Retroviral infection of EF43 cells, invasion assay (Matrigel), zymography/proteolytic assay, in vivo tumor transplantation\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined molecular mechanism with FGF-4 comparison as specificity control\",\n      \"pmids\": [\"9798677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Fgf3 and Fgf10 have redundant and dosage-sensitive requirements in murine cardiovascular development: compound mutants show a severity series affecting outflow tract, ventricular septum, AV cushions, ventricular myocardium, epicardium, and fourth pharyngeal arch artery; molecular marker analysis shows abnormalities in each cardiovascular progenitor population without loss of specification.\",\n      \"method\": \"Compound mouse mutants (allelic series), morphological analysis, molecular marker assessment at multiple time points\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic allelic series with defined molecular and morphological readouts, single lab\",\n      \"pmids\": [\"21664901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Craniofacial dysmorphology (craniosynostosis, Crouzon-like) in mice results from insertional mutation between Fgf3 and Fgf4, which upregulates expression of both Fgf3 and Fgf4 in cranial sutures, confirming FGF signaling pathway involvement in craniofacial development.\",\n      \"method\": \"Retroviral insertional mutagenesis, transcript analysis, in situ hybridization, histological phenotyping\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — molecular demonstration of gain-of-expression causing defined phenotype\",\n      \"pmids\": [\"9626498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Inducible FGF-3 expression in the mammary gland causes ductal hyperplasia by disrupting the balance between mitogenic and apoptotic signals; RU486 withdrawal reverses the phenotype, and synergism between FGF-3 mitogenic signaling and estrogen is required for pregnancy-dependent tumorigenesis.\",\n      \"method\": \"Mifepristone-inducible binary transgenic system, histological analysis, apoptosis/proliferation markers\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — inducible and reversible gain-of-function with mechanistic dissection of mitogenic vs. apoptotic balance\",\n      \"pmids\": [\"12169667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Inducible FGF-3 expression in adult mouse lung causes alveolar macrophage infiltration at low levels and diffuse alveolar type II cell hyperplasia at high levels; both phenotypes are reversible upon ligand withdrawal.\",\n      \"method\": \"Progesterone antagonist-responsive binary transgenic system, RU486 induction, histological analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — inducible and reversible gain-of-function with dose-dependent phenotypic readouts\",\n      \"pmids\": [\"11331772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Homozygous FGF3 mutations in humans (p.Leu6Pro within the signal peptide, predicted to impair secretion; and frameshift p.Ile85MetfsX15) cause LAMM syndrome (complete labyrinthine aplasia, microtia, microdontia), confirming FGF3 is required for human inner ear development and that signal peptide integrity is functionally important.\",\n      \"method\": \"Human genetics (sequencing in consanguineous families), co-segregation analysis, signal peptide prediction\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — human LOF mutations with predicted mechanism (signal peptide disruption); no in vitro secretion assay performed in this paper\",\n      \"pmids\": [\"18435799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Int-2 (FGF3) acts as an autocrine or ultra-short-range paracrine growth factor in mammary epithelium: transplanted mammary tissue expressing int-2 mRNA shows abnormal growth only within the transplant, with no effect on adjacent wild-type host epithelium.\",\n      \"method\": \"Transgenic tissue transplantation, in situ hybridization for cell-specific mRNA localization, mammary whole-mount analysis\",\n      \"journal\": \"Journal of the National Cancer Institute\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transplantation experiment with cell-level spatial readout, single lab\",\n      \"pmids\": [\"1317463\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FGF3 is a heparin-binding secreted growth factor (with an alternative nuclear-localized isoform arising from CUG-initiated translation, whose dual fate is governed by competing signal peptide and bipartite nuclear localization sequences) that signals through FGF receptors (preferentially FGFR2-IIIb) to drive otic placode induction and inner ear morphogenesis (redundantly with FGF10 and FGF8), hindbrain segmental identity via an r4 signaling center (activating MAPK/ERK → Pea3 → Krox20), adenohypophysis specification, epibranchial placode neurogenesis, and cardiovascular progenitor coordination, while its transcription is activated by SOX7/GATA-4 competition and repressed by a SOX6–CtBP2 complex, and its ligand activity is modulated by downstream BMP pathway cross-talk.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FGF3 is a heparin-binding secreted growth factor of the fibroblast growth factor family that functions as a key paracrine/autocrine signal in embryonic patterning, organogenesis, and epithelial proliferation. A single CUG-initiated translation product is partitioned between secretion (via signal peptide cleavage) and nuclear localization (via a bipartite NLS), and the secreted glycoprotein preferentially activates FGFR2-IIIb to drive MAPK/ERK signaling [PMID:8076608, PMID:8622866]. FGF3 acts redundantly with FGF8 and FGF10 to induce otic placode formation and inner ear morphogenesis, patterns hindbrain segmental identity through an r4 signaling center activating the Pea3→Krox20 cascade, specifies adenohypophyseal progenitors from the ventral diencephalon, and promotes epibranchial placode neurogenesis, while its transcription is positively regulated by SOX7/GATA-4 and repressed by a SOX6–CtBP2 complex [PMID:11437442, PMID:12810586, PMID:15229178, PMID:16077091, PMID:20553903, PMID:11504872, PMID:15082719]. Homozygous loss-of-function FGF3 mutations in humans cause LAMM syndrome (labyrinthine aplasia, microtia, and microdontia), confirming its essential role in inner ear and craniofacial development [PMID:18435799].\",\n  \"teleology\": [\n    {\n      \"year\": 1986,\n      \"claim\": \"Establishing FGF3 as a member of the FGF family resolved the identity of the int-2 proto-oncogene product, showing it encodes a ~27 kDa protein with FGF homology organized across at least three exons, with four mRNA classes from alternate start/polyadenylation sites.\",\n      \"evidence\": \"cDNA sequencing, Northern blot, primer extension, RNase protection in mouse\",\n      \"pmids\": [\"3013624\", \"2841106\", \"3416832\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No receptor specificity determined\", \"No functional activity demonstrated at this stage\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Demonstrating that FGF3 protein has mesoderm-inducing and mitogenic activity established it as a functional growth factor, not merely an oncogene-associated sequence.\",\n      \"evidence\": \"Xenopus animal cap mesoderm induction assay and mammalian fibroblast DNA synthesis assay\",\n      \"pmids\": [\"2483371\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor identity unknown\", \"In vivo developmental role not yet tested\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Transgenic overexpression causing mammary and prostatic epithelial hyperplasia demonstrated that FGF3 acts as a potent epithelial growth factor in vivo, linking it to oncogenic potential in specific tissues.\",\n      \"evidence\": \"MMTV-driven FGF3 transgenic mice with histological analysis\",\n      \"pmids\": [\"1690126\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of autocrine vs. paracrine action unclear\", \"Receptor specificity in mammary tissue unknown\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Transplantation studies and Wnt-1/FGF3 bitransgenic analysis established that FGF3 acts as an autocrine/ultra-short-range paracrine factor in mammary epithelium and cooperates with Wnt-1 in mammary tumorigenesis through complementary pathways.\",\n      \"evidence\": \"Transgenic mammary tissue transplantation; doubly transgenic Wnt-1/int-2 mice with tumor incidence analysis\",\n      \"pmids\": [\"1317463\", \"1530875\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of Wnt-1 and FGF3 pathway complementation not defined\", \"Identity of cooperating downstream effectors unknown\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Two landmark discoveries — Fgf3 knockout mice showing tail and inner ear defects, and biochemical characterization of secreted glycosylated FGF3 forms binding heparin and activating FGFR1/2 — jointly established FGF3 as a heparin-binding FGFR ligand required for otic vesicle morphogenesis and tail bud development.\",\n      \"evidence\": \"Targeted gene disruption in mouse; COS-1 cell expression with heparin-Sepharose binding, glycosylation analysis, and FGFR-dependent mitogenicity assays\",\n      \"pmids\": [\"8223243\", \"8223431\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific FGFR isoform preference not yet resolved\", \"Redundancy with other FGFs in ear development not addressed\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Demonstrating that a single CUG-initiated FGF3 translation product is partitioned between secretory and nuclear fates by competing signal peptide and bipartite NLS resolved the long-standing question of how one mRNA generates two functionally distinct protein pools.\",\n      \"evidence\": \"In vitro translation, COS-1 transfection, deletion/replacement mutagenesis, heterologous fusion proteins\",\n      \"pmids\": [\"8076608\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of nuclear FGF3 undefined\", \"Regulatory mechanism controlling secretory vs. nuclear partitioning in vivo unknown\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Receptor binding studies with zebrafish/Xenopus FGF3 chimeras established preferential binding to FGFR2-IIIb over IIIc, with C-terminal sequences determining receptor affinity, mitogenic potency, and transforming activity.\",\n      \"evidence\": \"COS-1 transfection, competition receptor binding assay, chimeric protein analysis\",\n      \"pmids\": [\"8622866\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of FGF3–FGFR2 complex unavailable\", \"Whether FGFR2-IIIb preference holds in all vertebrate orthologs untested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identification of SOX6–CtBP2 as a transcriptional repressor complex at the Fgf3 promoter, with mutually exclusive SOX6/FGF3 expression in the otic vesicle, established the first direct transcriptional regulatory mechanism for FGF3.\",\n      \"evidence\": \"Yeast one-hybrid/two-hybrid, reporter gene assay, mutagenesis, in situ hybridization\",\n      \"pmids\": [\"11504872\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SOX6–CtBP2 repression operates in tissues other than otic vesicle unknown\", \"Chromatin-level mechanism not characterized\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Morpholino/mutant studies in zebrafish demonstrated that FGF3 and FGF8 redundantly induce otic placode formation, explaining why single-gene knockouts have moderate phenotypes and establishing the principle of FGF ligand redundancy in otic induction.\",\n      \"evidence\": \"Antisense morpholino knockdown combined with fgf8 (ace) genetic mutant, double depletion, otic marker in situ hybridization\",\n      \"pmids\": [\"11437442\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signal transduction pathway in otic precursors not mapped\", \"Whether redundancy extends to other FGF family members not excluded\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing that FGF3/FGF8 from rhombomere 4 are the instructive signals for both otic placode induction and hindbrain segmental identity (r5/r6) unified two developmental processes under one signaling mechanism.\",\n      \"evidence\": \"Morpholino knockdown, r4 cell transplantation, gain-of-function misexpression in zebrafish\",\n      \"pmids\": [\"11959820\", \"12121619\", \"12135921\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How r4 cells restrict FGF3 expression to produce a sharp boundary undefined\", \"Downstream transcription factor targets in r5/r6 specification beyond Krox20 not fully catalogued\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Mouse Fgf3/Fgf10 double knockouts lacking otic vesicles entirely established that FGF3 and FGF10 (rather than FGF8) are the functionally redundant pair in mammalian otic induction, with a quantitative dosage requirement.\",\n      \"evidence\": \"Double knockout mouse genetics with allelic series and otic marker analysis\",\n      \"pmids\": [\"12810586\", \"14623822\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FGF3 and FGF10 activate identical intracellular cascades in otic tissue untested\", \"Cell-autonomous vs. paracrine contributions in mammals not resolved at single-cell level\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery that SOX7 and GATA-4 competitively activate FGF3 transcription through the same PS4A element, modulated by SOX2, provided the first activating transcriptional mechanism and showed context-dependent promoter occupancy.\",\n      \"evidence\": \"Reporter assay, EMSA, RNAi in ES cells, co-expression experiments\",\n      \"pmids\": [\"15082719\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo chromatin occupancy at the endogenous Fgf3 locus not shown\", \"How SOX7/GATA-4 competition is resolved in specific tissues unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that Fgf3 from the ventral diencephalon is required for adenohypophysis specification (lim3, pit1 induction) independently of Shh expanded FGF3's known roles beyond ear to pituitary development.\",\n      \"evidence\": \"Zebrafish fgf3 (lia) null mutant analysis with marker gene expression and Shh epistasis\",\n      \"pmids\": [\"15229178\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"FGFR isoform mediating pituitary response unknown\", \"Whether FGF3 acts alone or redundantly with other FGFs in mammalian pituitary not tested\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showing that endoderm-derived FGF3 from pharyngeal pouches is necessary and sufficient for epibranchial placode neurogenesis, acting downstream of initial placode induction, defined a new tissue-specific role for FGF3.\",\n      \"evidence\": \"Morpholino knockdown, mosaic tissue transplantation, ectopic expression, endoderm-deficient embryos in zebrafish\",\n      \"pmids\": [\"16077091\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor and intracellular pathway in epibranchial placode neurons not identified\", \"Whether other FGFs compensate partially in epibranchial context unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identification of human homozygous FGF3 loss-of-function mutations causing LAMM syndrome confirmed that FGF3 is essential for human inner ear, external ear, and dental development and that signal peptide integrity is critical for function.\",\n      \"evidence\": \"Sequencing of consanguineous families, co-segregation analysis, signal peptide prediction\",\n      \"pmids\": [\"18435799\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vitro secretion assay performed for the mutant proteins\", \"Genotype-phenotype correlation across different FGF3 mutations limited\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Placing FGF3 upstream of MAPK/ERK→Pea3→Krox20 in chick hindbrain completed the signaling cascade linking FGF3 to rhombomere boundary specification.\",\n      \"evidence\": \"Morpholino knockdown in chick, ERK phosphorylation analysis, Pea3 gain/loss-of-function\",\n      \"pmids\": [\"20553903\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether FGF3 activates other MAPK cascade effectors besides Pea3 not tested\", \"Single-lab result awaits independent replication\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Compound Fgf3/Fgf10 mutant allelic series in mouse revealed dosage-sensitive redundancy in cardiovascular development, extending FGF3 function to outflow tract, ventricular septum, epicardium, and pharyngeal arch artery morphogenesis.\",\n      \"evidence\": \"Compound mouse mutant allelic series with morphological and molecular marker analysis\",\n      \"pmids\": [\"21664901\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"FGFR mediating cardiovascular response not identified\", \"Whether FGF3 cardiovascular role is direct or secondary to pharyngeal endoderm signaling unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrating that FGF3 from presomitic mesoderm restrains BMP signaling in adjacent neuroepithelium — with genetic epistasis showing BMP pathway reduction rescues Fgf3 mutant neural tube and crest defects — established FGF3 as a cross-talk node between FGF and BMP pathways during axis extension.\",\n      \"evidence\": \"Fgf3 null mouse, BMP receptor/Noggin compound mutants, BMP4 treatment of PSM progenitors in vitro\",\n      \"pmids\": [\"27144312\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular mechanism by which FGF3 suppresses BMP transcription/signaling not defined\", \"Whether this FGF–BMP cross-talk operates in other axial tissues unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the biological function of nuclear FGF3, the structural basis of FGFR2-IIIb selectivity, and whether FGF3 plays roles in adult tissue homeostasis beyond developmental contexts.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Function of nuclear FGF3 isoform entirely uncharacterized\", \"No crystal structure of FGF3–receptor complex\", \"Adult physiological roles remain unexplored\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [2, 3, 6, 7, 8, 11]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [6, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [5, 6, 7]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [6, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 7, 8, 19]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 8, 9, 10, 11, 12, 13, 14]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"FGFR2\",\n      \"SOX6\",\n      \"CTBP2\",\n      \"SOX7\",\n      \"GATA4\",\n      \"FGF8\",\n      \"FGF10\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}